CSIMarket
 
Quest Diagnostics Inc  (DGX)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

Quest Diagnostics Inc Income Statement Quarterly

DGX


Select the Financial Report:   Period:   Fiscal Year:

INCOME STATEMENT
(Quarterly GAAP In millions $)

(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
Revenue From Contract With Customer Excluding Assessed Tax 2,331.00 2,486.00 2,453.00 2,611.00
Total Revenue 2,331.00 2,333.00 2,486.00 2,453.00 2,611.00
Cost of Revenue 1,560.00 1,575.00 1,618.00 1,611.00 1,646.00
Gross Profit 771.00 758.00 868.00 842.00 965.00
Selling, Administration, Marketing 439.00 563.00 464.00 422.00 425.00
Depriciation & Amortization 26.00 39.00 27.00 27.00 27.00
Research & development - - - - -
Restructuring charges - - - - -
Other exp. /-income 1.00 21.00 -15.00 5.00 -
Special charge - - - - -
Total operating costs including COS 2,026.00 2,198.00 2,094.00 2,065.00 2,098.00
Operating income/-loss 305.00 135.00 392.00 388.00 513.00
Other Deductions / - Income
Interest expense 35.00 32.00 33.00 36.00 37.00
Interest income - - - - -
Net interest expense/-income 35.00 32.00 33.00 36.00 37.00
Loss (Income) from Equity Method Investments - - - - -
Minority Interests Income/ -Loss - - - - -
Sale of assets - - - - -
Financing Loss/ -Income - - - - -
Other loss/ -income -7.00 -6.00 8.00 29.00 24.00
Total costs & expenses 2,054.00 2,224.00 2,135.00 2,130.00 2,159.00
Income /-loss before income taxes 277.00 109.00 351.00 323.00 452.00
Income taxes expenses/-benefit 65.00 -4.00 81.00 77.00 110.00
Income after income taxes 217.00 116.00 276.00 250.00 373.00
Net income/-loss of other equity 5.00 3.00 6.00 4.00 31.00
Income/-loss from cont. Ops. 217.00 116.00 276.00 250.00 373.00
Accounting change - - - - -
Discontinued operations - - - - -
Extraordinary items - - - - -
Net Income/-loss 217.00 116.00 276.00 250.00 373.00
Noncontrolling interests 15.00 15.00 20.00 16.00 18.00
Prefered dividends - - - - -
Other - - - - -
Income/-loss to shareholder 202.00 101.00 256.00 234.00 355.00
EBIT 312.00 141.00 384.00 359.00 489.00
EBITD 419.00 257.00 492.00 466.00 595.00
EBITDA 419.00 257.00 492.00 466.00 595.00


Per Share (GAAP Quarterly, in $) (Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
Basic EPS (excl. extra items) 1.80 0.88 2.20 2.00 2.97
   Extraordinary items 0.00 0.00 0.00 0.00 0.00
Basic Net EPS 1.80 0.88 2.20 2.00 2.97
Basic shares outstanding (Mill. of Units) 112.00 115.16 116.00 117.00 119.00
   EPS other shares - - - - -
Diluted Net EPS 1.78 0.88 2.17 1.96 2.92
Diluted average shares (Mill. of Units) 113.00 118.70 118.00 119.00 121.00
Dividend per share 0.655 0.632 0.661 0.655 0.612



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071